Substrate‐Bound β‐Amyloid Peptides Inhibit Cell Adhesion and Neurite Outgrowth in Primary Neuronal Cultures
暂无分享,去创建一个
C. Masters | R. Postuma | D. Small | K. Beyreuther | C. Barrow | J. Nunan | Weilan He
[1] C. Barrow,et al. The Aβ 3-Pyroglutamyl and 11-Pyroglutamyl Peptides Found in Senile Plaque Have Greater β-Sheet Forming and Aggregation Propensities in Vitro than Full-Length Aβ† , 1999 .
[2] David H. Small,et al. Alzheimer's Disease and the Amyloid β Protein , 1999 .
[3] F. Engert,et al. Dendritic spine changes associated with hippocampal long-term synaptic plasticity , 1999, Nature.
[4] M. Hasselmo,et al. Plaque-induced neurite abnormalities: implications for disruption of neural networks in Alzheimer's disease. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[5] P. Reiner,et al. Regulation of Amyloid Precursor Protein Cleavage , 1999, Journal of neurochemistry.
[6] George B. Benedek,et al. Temperature dependence of amyloid β-protein fibrillization , 1998 .
[7] C. Masters,et al. Survival of Cultured Neurons from Amyloid Precursor Protein Knock-Out Mice against Alzheimer’s Amyloid-β Toxicity and Oxidative Stress , 1998, The Journal of Neuroscience.
[8] Bruce A. Yankner,et al. Aging renders the brain vulnerable to amyloid β-protein neurotoxicity , 1998, Nature Medicine.
[9] T. Morgan,et al. Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[10] M. Tolar,et al. Sympathetic neurite outgrowth is greater on plaque-poor vs. plaque-rich regions of Alzheimer's disease cryostat sections , 1998, Brain Research.
[11] J. Hardy,et al. Increased Aβ42(43) from cell lines expressing presenilin 1 mutations , 1998, Annals of neurology.
[12] T. Wight,et al. Perlecan Binds to the β‐Amyloid Proteins (Aβ) of Alzheimer's Disease, Accelerates Aβ Fibril Formation, and Maintains Aβ Fibril Stability , 1997 .
[13] C. Behl. Amyloid β-protein toxicity and oxidative stress in Alzheimer’s disease , 1997, Cell and Tissue Research.
[14] D. Peterson,et al. Mechanism of Cellular 3‐(4,5‐Dimethylthiazol‐2‐yl)‐2,5‐Diphenyltetrazolium Bromide (MTT) Reduction , 1997, Journal of neurochemistry.
[15] N. Inestrosa,et al. Laminin inhibits amyloid-β-peptide fibrillation , 1996, Neuroscience Letters.
[16] D. Small,et al. Role of Proteoglycans in Neural Development, Regeneration, and the Aging Brain , 1996, Journal of neurochemistry.
[17] B. Yankner. Mechanisms of Neuronal Degeneration in Alzheimer's Disease , 1996, Neuron.
[18] D. Small,et al. Expression of the amyloid protein precursor of Alzheimer's disease in the developing rat olfactory system. , 1995, Brain research. Developmental brain research.
[19] V. Nurcombe,et al. Cholinergic regulation of neurite outgrowth from isolated chick sympathetic neurons in culture , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[20] B. Yankner,et al. Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[21] L. Thal,et al. Lack of long-term effects after β-amyloid protein injections in rat brain , 1994, Neurobiology of Aging.
[22] S. Younkin,et al. An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants. , 1994, Science.
[23] D. Snow,et al. Interactions of developing neurons with the extracellular matrix , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[24] D. McLachlan,et al. Alzheimer Aβ Amyloid Forms an Inhibitory Neuronal Substrate , 1994 .
[25] B. Hyman,et al. Apolipoprotein E in sporadic Alzheimer's disease: Allelic variation and receptor interactions , 1993, Neuron.
[26] N. Inestrosa,et al. Extracellular matrix components and amyloid in neuritic plaques of Alzheimer's disease. , 1993, General pharmacology.
[27] L. Reichardt,et al. Extracellular Matrix 2: Role of extracellular matrix molecules and their receptors in the nervous system , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[28] P. Lansbury,et al. Seeding “one-dimensional crystallization” of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie? , 1993, Cell.
[29] D. Selkoe,et al. Amyloid beta-protein as a substrate interacts with extracellular matrix to promote neurite outgrowth. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[30] A. Delacourte,et al. Binding of secreted human neuroblastoma proteoglycans to the Alzheimer's amyloid A4 peptide , 1993, Brain Research.
[31] P. Fraser,et al. Effects of Sulfate Ions on Alzheimer β/A4 Peptide Assemblies: Implications for Amyloid Fibril‐Proteoglycan Interactions , 1992, Journal of neurochemistry.
[32] Brian J Cummings,et al. beta-Amyloid induces neuritic dystrophy in vitro: similarities with Alzheimer pathology. , 1992, Neuroreport.
[33] C. Masters,et al. The amyloid protein precursor of Alzheimer's disease is a mediator of the effects of nerve growth factor on neurite outgrowth , 1992, Neuron.
[34] E. Masliah,et al. Localization of amyloid precursor protein in GAP43-immunoreactive aberrant sprouting neurites in Alzheimer's disease , 1992, Brain Research.
[35] M. Mattson,et al. beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[36] Carl W. Cotman,et al. In vitro aging of ß-amyloid protein causes peptide aggregation and neurotoxicity , 1991, Brain Research.
[37] M. Beal,et al. An in vivo model for the neurodegenerative effects of beta amyloid and protection by substance P. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[38] J. Ulrich,et al. Alzheimer's Disease: A Description of the Structural Lesions , 1991, Brain pathology.
[39] K. Grzeschik,et al. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor , 1987, Nature.
[40] James L. McClelland,et al. Amnesia and distributed memory , 1986 .
[41] C. Masters,et al. Amyloid plaque core protein in Alzheimer disease and Down syndrome. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[42] P C Letourneau,et al. Cell-to-substratum adhesion and guidance of axonal elongation. , 1975, Developmental biology.
[43] V. Nurcombe,et al. Avian sympathetic ganglia , 1999 .
[44] C. Franceschi,et al. In vitro peroxidase oxidation induces stable dimers of beta-amyloid (1-42) through dityrosine bridge formation. , 1999, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.
[45] D. Small,et al. Alzheimer's disease and the amyloid beta protein: What is the role of amyloid? , 1999, Journal of neurochemistry.
[46] B. Greenberg,et al. An interaction between basement membrane and Alzheimer amyloid precursor proteins suggests a role in the pathogenesis of Alzheimer's disease. , 1995, Laboratory investigation; a journal of technical methods and pathology.
[47] E. Engvall,et al. Extracellular matrix components , 1994 .
[48] D. Selkoe,et al. Microinjection of synthetic amyloid beta-protein in monkey cerebral cortex fails to produce acute neurotoxicity. , 1993, The American journal of pathology.
[49] G. Glenner,et al. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. , 1984, Biochemical and biophysical research communications.
[50] Effects of injected Alzheimer f3-amyloid cores in rat brain , 2022 .